T. Rowe Price Investment Management, Inc. Sarepta Therapeutics, Inc. Call Options Transaction History
T. Rowe Price Investment Management, Inc.
- $166 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SRPT
# of Institutions
530Shares Held
84.5MCall Options Held
2.06MPut Options Held
1.52M-
Black Rock Inc. New York, NY10.3MShares$1.31 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$1.14 Billion0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$793 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$552 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$541 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $11.1B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...